奇正藏藥(002287.SZ):擬以1億元參設武漢華實勁鴻私募股權投資基金
格隆匯11月9日丨奇正藏藥(002287.SZ)公佈,2021年11月8日,公司全資子公司甘肅佛閣藏藥有限公司(“甘肅佛閣”)與華實浩瑞(武漢)資產管理有限公司(“華實浩瑞”)、深圳市紅塔資產管理有限公司(“紅塔資產”)、北京凱韋誠投資管理有限責任公司(“凱韋誠”)、北斗銀泰投資有限公司(“北斗銀泰”)、湖北瑞鑫實業有限公司(“湖北瑞鑫”)、華石鴻洛(珠海)實業投資合夥企業(有限合夥)(“華石鴻洛”)、武漢海興房地產開發有限公司(“武漢海興”)、黎雅婷簽訂《武漢華實勁鴻私募股權投資基金合夥企業(有限合夥)合夥協議》,共同設立武漢華實勁鴻私募股權投資基金合夥企業(有限合夥)(以工商註冊為準,“合夥企業”、“基金”),總規模3億元,甘肅佛閣作為有限合夥人以自有資金認繳出資1億元,認繳比例33.33%。
投資領域:合夥企業投資上市公司(不含地產、白酒行業)的非公開發行股票(即定向增發股票)、以詢價轉讓方式投資於上市公司股票(不含地產、白酒行業),也可投資於銀行存款(包括定期存款、協議存款和其他存款)、同業存單、大額可轉讓定期存單、銀行理財、債券逆回購、國債、中央銀行票據、貨幣市場基金以及證券公司發行的收益憑證。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.